Abstract
32 patients were analyzed in our examinations, patients were treated on an outpatient basis in 2017-2022. 9.10 ± 0.04 cm before treatment of VAS in patients 2 weeks before RChNA, and after 1, 3, 6, 12 months. After 1 month, RChNA was 3.96 ± 0.28 cm (r ≤ 0.05) in patients with reduced pain in the VASh group. This condition was maintained for up to 3 months. The positive result in this group is 4.33 ± 0.29 cm; maintained, in 6 months – 4.46 ± 0.32 cm; and in 12 months - 5.01 ± 0.34 cm (r ≤ 0.05) indicator.
Users
Please
log in to take part in the discussion (add own reviews or comments).